Schettini G, Rogol A D, MacLeod R M, Yasumoto T, Cronin M J
Eur J Pharmacol. 1985 Mar 12;109(3):335-40. doi: 10.1016/0014-2999(85)90393-0.
The 235-1 pituitary tumor clone was utilized to study prolactin secretion after perturbing cyclic AMP and calcium metabolism. Cellular cyclic AMP levels were elevated after treatment with PGE1, cholera toxin, forskolin, isobutylmethylxanthine as well as dibutryl cyclic AMP; these cyclic AMP responses were associated with increased prolactin release. Ionophore A23187 and maitotoxin, which enhance calcium uptake into cells, also amplified prolactin secretion. In contrast, the calmodulin antagonists penfluridol and W7 reduced basal prolactin release. These data support the hypothesis that cyclic AMP, calcium and calmodulin can participate in prolactin release from 235-1 cells.
利用235-1垂体肿瘤克隆来研究在干扰环磷酸腺苷(cAMP)和钙代谢后催乳素的分泌情况。用前列腺素E1(PGE1)、霍乱毒素、福斯高林、异丁基甲基黄嘌呤以及二丁酰环磷酸腺苷(dibutryl cyclic AMP)处理后,细胞内的环磷酸腺苷水平升高;这些环磷酸腺苷反应与催乳素释放增加有关。离子载体A23187和刺尾鱼毒素可增强细胞对钙的摄取,它们也能放大催乳素的分泌。相反,钙调蛋白拮抗剂五氟利多和W7可降低基础催乳素释放。这些数据支持以下假说:环磷酸腺苷、钙和钙调蛋白可参与235-1细胞中催乳素的释放。